Serious anaphylactoid reactions to polygeline (Haemaccel®, Hoechst) were reported by Ring and Messner in 1977 to have an incidence of 0.049070 (1 in 2,050). I Since that time, modification of the manufacturing process has occurred. 2 This had led to the belief that there are fewer reactions and these are generally of a minor nature. Although the exact incidence is not known, severe reactions to Haemaccel continue to occur. 3 -' We report a cardiovascular collapse accompanied by cardiac arrest following a small-volume infusion of Haemaccel. Resuscitation was successful. Subsequent intradermal skin-testing for Haemaccel was strongly positive.
CASE REPORT
An 83-year-old female weighing 47 kg was scheduled to have a thoracotomy for a cavitation lesion of the left lower lobe. The pathology was a known bronchogenic squamous cell carcinoma. The cavitation had resulted in two episodes of pneumothorax for which an intercostal drain was still in place. Planned surgery involved a wedge resection of the mass or, if necessary, a left lower lobectomy.
Six months previously she had. a right femoropopliteal bypass graft under general anaesthesia, during which one litre of Haemaccel was infused uneventfully. There was a history of allergy to penicillin but the details were obscure. Smoking history was 40 pack years. Current medication consisted of digoxin, frusemide, amiloride, diclofenac and aspirin. All drugs were withheld on the day of operation. Premedication was with oral temazepam 10 mg, which resulted in effective sedation.
After insertion of a 16-gauge intravenous cannula into each arm, a 20-gauge cannula was passed into the right radial artery for direct intra-arterial blood pressure monitoring. Pre-oxygenation was begun and anaesthesia induced with fentanyl 100 p.g, midazolam 2 mg and thiopentone 100 mg. Following muscle relaxation with suxamethonium 100 mg, rigid bronchoscopy was performed by the surgeon. He observed normal airways with minimal secretion. A medium, left-sided, red rubber double-lumen endobronchial tube was inserted easily, with correct position being confirmed by auscultation. Vecuronium 4 mg was given prior to transfer from the anaesthetic room into the operating theatre.
Five minutes later the systolic blood pressure was noticed to have declined from 120 to 80 mm Hg. The isoflurane vaporiser was turned off and ephedrine 6 mg given intravenously, resulting in a systolic blood pressure of 160 mm Hg. The 500 ml Hartmann's solution was nearly completed and, in expectation of a further fall in blood pressure in this cachectic elderly patient when turned to the full lateral position, an infusion of Haemaccel was commenced. The patient was turned onto her right side and positioned for the left thoracotomy. Within one minute the direct arterial blood pressure reading was 30 mm Hg. At the same time it was noticed that the dependant, right side of the body was erythematous while the upper half was deathly white.
Anaphylaxis was immediately suspected. The temporal relationship to the administration of the Haemaccel suggested that this was the cause. The infusion was turned off and 2 ml of 1:10,000 adrenaline administered intravenously. She was turned supine and, as the systolic blood pressure remained at 40 mm Hg, with no palpable pulses, cardiac massage was begun. Normal saline was run rapidly through the other intravenous line while a nurse obtained 5% Normal Serum Albumin (NSA). Simultaneously, the remaining 8 ml of the adrenaline was injected slowly over two minutes. No cardiac output was detectable and the electrocardiographic tracing changed from sinus rhythm to coarse ventricular fibrillation. This reverted to sinus rhythm with a single 360 Joule discharge. Rapid infusion of 5% NSA to a total of 1.5 litres was given over the next 15 minutes, and adrenaline 1:10,000 to a total of 2.5 mg was continuously administered. By this time the systolic blood pressure was 80 mm Hg, femoral pulses were easily palpable and cardiac massage was ceased. Sodium bicarbonate 50 mmol had also been injected during the resuscitation process.
Interestingly, at no time was bronchospasm detected on auscultation and manual ventilation on 100% oxygen was easy to perform. Perhaps this was a consequence of the early use of adrenaline.
In view of this life-threatening episode the planned operation was abandoned. The double-lumen tube was removed and replaced by a 7.0 mm single-lumen plastic endotracheal tube. The surgeon re-inserted an underwater seal drain into the left pleural cavity. A size 7 FG double-lumen catheter was passed into the left internal jugular vein to enable the continuous infusion of adrenaline at 12 jtg/minute. The patient was transferred to the Intensive Care Unit were IPPV was maintained for four hours, by which time she was awake, alert and had a blood pressure of 130/90 mm Hg. The adrenaline infusion was then ceased.
On arrival in ICU her whole body was markedly flushed, with the exception of the left lower leg which, in contrast, was pale and poorly perfused. A glyceryl trinitrate infusion improved circulation to that limb.
Extubation was achieved next morning and the patient continued to improve rapidly. The chest drain was removed. In fact, she has had no further pneumothoraces, so the reaction has resulted in her avoiding a thoracotomy. However, it may have accelerated the requirement for a left femoropopliteal bypass! Blood taken in ICU 90 minutes after the reaction revealed the following, with reference ranges in brackets: Thirty-seven days following the reaction, intradermal skin testing was performed after the manner described by Fisher. 6 All drugs used for the anaesthetic, as well as ephedrine and saline, were tested, with no response being elicited. However, Haemaccel diluted 1 ml in 100 ml of saline produced a rapid response in less than ten minutes. The wheal was greater than 1 cm in diameter and the flare approximately 2 cm. 2 The reaction persisted for well over one hour and was accompanied by local itching. No respiratory symptoms were experienced and the blood pressure remained unchanged.
The next day, vascular surgery to the left leg was carried out under spinal anaesthesia, with Hartmann's solution being used as the intravenous fluid. Ephedrine was the only medication. There were no ill effects. 
DISCUSSION
Concern about blood transfusions by both staff and patients has resulted in greater use of alternative colloid solutions. The 5070 NSA which has now replaced Stable Plasma Protein Solution (SPPS) is in comparatively short supply and, being a blood product, is not acceptable to some patients. There is thus increasing use of synthetic colloid solutions. The volume of dextran solutions which may be infused is limited by their interference with platelet activity, resulting in a tendency to cause bleeding. There would seem to be a higher incidence of severe reaction to dextran of 1:821. 7 Deaths continue to be reported. 7 • 8 Hydroxyethyl starch is widely used overseas as a plasma expander, with the incidence of severe reactions being reported as 1:16,000; 1 however, products such as Hetastarch are not available in Australia. For all these reasons, Haemaccel is becoming the plasma expander of first choice in this country. It it generally believed that the anaphylactoid reactions associated with Haemaccel are solely due to histamine release and do not have any immunological mediation",Jo However, the reaction in the patient described here gave every indication of an antigen-antibody reaction in that profound cardiovascular collapse occurred following an infusion of approximately 10 ml of Haemaccel. The patient subsequently had a strongly positive reaction to Haemaccel on skin testing. This test is thought by Fisher to be of no value. 6 However, other workers have found it to be useful and believe that, although the immunogenicity of modified gelatins is weak, clinical intolerance may be due to the presence of specific antibodies in some individuals. II The positive response in this patient confirms that skin testing may indeed be a very valuable test which should form part of any subsequent investigation into the cause of anaphylactoid reactions. Since she had received Haemaccel uneventfully at an operation six months previously, the possibility of antibody development does exist. If so, this is a worrying feature as many thousands of individuals would by now have received Haemaccel in the past. The single estimation of complement levels did not contribute much to the diagnosis, which was made essentially on clinical grounds. Since the diagnosis was not in doubt, and rapid recovery followed appropriate resuscitation, no further blood samples were taken.
There has been no large-scale study of the incidence of reactions to Haemaccel since a change in the manufacturing process reduced the amount of free diisocyanate thought to be responsible for histamine release. s However, by March 1993 reports of 44 severe hypersensitivity reactions to Haemaccel had been provided to ADRAC by Australian prescribers. 12 The indications for its use should be followed and contraindications observed. In particular, the manufacturers advise against rapid infusion to normovolaemic individuals. \3 The practice of administering Haemaccel to patients prior to, or during, central neural blockade must be questioned. Two deaths have been reported when Haemaccel was given to patients having epidural anaesthesia: it has been suggested that an epidural block complicates anaphylaxis by abolishing compensatory vasoconstriction and catecholamine release!, 14 In particular, pre-Ioading pregnant women with Haemaccel for epidural or spinal anaesthesia may produce a complex clinical picture. Any resultant hypotension could be attributed to sympathetic block, anaphylactoid reaction, inferior vena caval compression or any combination of the three. In a study involving eleven pregnant women, Lund found that six showed allergic manifestations after an infusion of Haemaccel, including two in connection with epidural analgesia. 15 Berg considers pregnancy to be a contraindication to the use of Dextran-70. 8 The end of the crystalloid era has been heralded previously. 16 However, the use of colloid alternatives is not without risk. Life-threatening episodes such as we have described need to be reported so that the real risk of administration can be determined.
Appropriate indications for use and avoidance in those situations where these substances are not recommended should go some way to improving safety. A high index of suspicion, a rapid diagnosis and early institution of appropriate treatment should reduce the complications of anaphylaxis caused by colloids and by other drugs used in anaesthesia. 17, 18 
